ZC3HAV1 and colorectal cancer: Future studies should combine proteomic analyses with detailed functional assays in both wild-type and PARP13 KO HT29 to fully elucidate the role of PARP13 in modulating gene regulation, cell survival and therapy resistance in colorectal cancer models.